Stan Gibson was quoted in Forbes.com and Genetic Engineering and Biotechnology News on March 29, 2007 in an article titled, "Cancer Therapeutics Laboratories Files Cross - Complaint Against Licensor for Return of Cancer Therapy Technology."
Lawyer(s)
Share
